BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35996090)

  • 41. CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study.
    Laghi L; Bianchi P; Miranda E; Balladore E; Pacetti V; Grizzi F; Allavena P; Torri V; Repici A; Santoro A; Mantovani A; Roncalli M; Malesci A
    Lancet Oncol; 2009 Sep; 10(9):877-84. PubMed ID: 19656725
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic Significance of Tumour Budding and Desmoplastic Reaction in Intestinal-Type Gastric Adenocarcinoma.
    Pun C; Luu S; Swallow C; Kirsch R; Conner JR
    Int J Surg Pathol; 2023 Sep; 31(6):957-966. PubMed ID: 35726174
    [No Abstract]   [Full Text] [Related]  

  • 43. International consensus guidelines for scoring the histopathological growth patterns of liver metastasis.
    van Dam PJ; van der Stok EP; Teuwen LA; Van den Eynden GG; Illemann M; Frentzas S; Majeed AW; Eefsen RL; Coebergh van den Braak RRJ; Lazaris A; Fernandez MC; Galjart B; Laerum OD; Rayes R; Grünhagen DJ; Van de Paer M; Sucaet Y; Mudhar HS; Schvimer M; Nyström H; Kockx M; Bird NC; Vidal-Vanaclocha F; Metrakos P; Simoneau E; Verhoef C; Dirix LY; Van Laere S; Gao ZH; Brodt P; Reynolds AR; Vermeulen PB
    Br J Cancer; 2017 Nov; 117(10):1427-1441. PubMed ID: 28982110
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential regulation of extracellular matrix proteins in three recurrent liver metastases of a single patient with colorectal cancer.
    Voß H; Wurlitzer M; Smit DJ; Ewald F; Alawi M; Spohn M; Indenbirken D; Omidi M; David K; Juhl H; Simon R; Sauter G; Fischer L; Izbicki JR; Molloy MP; Nashan B; Schlüter H; Jücker M
    Clin Exp Metastasis; 2020 Dec; 37(6):649-656. PubMed ID: 33099724
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cancer-Associated Fibroblasts and Desmoplastic Reactions Related to Cancer Invasiveness in Patients With Colorectal Cancer.
    Shin N; Son GM; Shin DH; Kwon MS; Park BS; Kim HS; Ryu D; Kang CD
    Ann Coloproctol; 2019 Feb; 35(1):36-46. PubMed ID: 30879282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy.
    Halama N; Michel S; Kloor M; Zoernig I; Benner A; Spille A; Pommerencke T; von Knebel DM; Folprecht G; Luber B; Feyen N; Martens UM; Beckhove P; Gnjatic S; Schirmacher P; Herpel E; Weitz J; Grabe N; Jaeger D
    Cancer Res; 2011 Sep; 71(17):5670-7. PubMed ID: 21846824
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumour budding: a promising parameter in colorectal cancer.
    Lugli A; Karamitopoulou E; Zlobec I
    Br J Cancer; 2012 May; 106(11):1713-7. PubMed ID: 22531633
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Histopathological growth pattern of liver metastases as an independent marker of metastatic behavior in different primary cancers.
    Bohlok A; Richard F; Lucidi V; Asmar AE; Demetter P; Craciun L; Larsimont D; Hendlisz A; Van Laethem JL; Dirix L; Desmedt C; Vermeulen P; Donckier V
    Front Oncol; 2023; 13():1260880. PubMed ID: 37965465
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histopathological growth patterns and positive margins after resection of colorectal liver metastases.
    Nierop PMH; Höppener DJ; van der Stok EP; Galjart B; Buisman FE; Balachandran VP; Jarnagin WR; Kingham TP; Allen PJ; Shia J; Vermeulen PB; Groot Koerkamp B; Grünhagen DJ; Verhoef C; D'Angelica MI
    HPB (Oxford); 2020 Jun; 22(6):911-919. PubMed ID: 31735649
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prediction of Clinical Precision Chemotherapy by Patient-Derived 3D Bioprinting Models of Colorectal Cancer and Its Liver Metastases.
    Sun H; Sun L; Ke X; Liu L; Li C; Jin B; Wang P; Jiang Z; Zhao H; Yang Z; Sun Y; Liu J; Wang Y; Sun M; Pang M; Wang Y; Wu B; Zhao H; Sang X; Xing B; Yang H; Huang P; Mao Y
    Adv Sci (Weinh); 2024 Jan; 11(2):e2304460. PubMed ID: 37973557
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    Martinou E; Moller-Levet C; Karamanis D; Bagwan I; Angelidi AM
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216396
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differentiation of histopathological growth patterns of colorectal liver metastases by MRI features.
    Li WH; Wang S; Liu Y; Wang XF; Wang YF; Chai RM
    Quant Imaging Med Surg; 2022 Jan; 12(1):608-617. PubMed ID: 34993105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia.
    Stessels F; Van den Eynden G; Van der Auwera I; Salgado R; Van den Heuvel E; Harris AL; Jackson DG; Colpaert CG; van Marck EA; Dirix LY; Vermeulen PB
    Br J Cancer; 2004 Apr; 90(7):1429-36. PubMed ID: 15054467
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumour budding/T cell infiltrates in colorectal cancer: proposal of a novel combined score.
    Dawson H; Christe L; Eichmann M; Reinhard S; Zlobec I; Blank A; Lugli A
    Histopathology; 2020 Mar; 76(4):572-580. PubMed ID: 31560788
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.
    Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K
    Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential CXC receptor expression in colorectal carcinomas.
    Rubie C; Kollmar O; Frick VO; Wagner M; Brittner B; Gräber S; Schilling MK
    Scand J Immunol; 2008 Dec; 68(6):635-44. PubMed ID: 18959627
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer.
    Zlobec I; Terracciano L; Tornillo L; Günthert U; Vuong T; Jass JR; Lugli A
    Gut; 2008 Oct; 57(10):1413-9. PubMed ID: 18436576
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastases.
    Kroemer M; Turco C; Spehner L; Viot J; Idirène I; Bouard A; Renaude E; Deschamps M; Godet Y; Adotévi O; Limat S; Heyd B; Jary M; Loyon R; Borg C
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33229508
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Histopathological growth patterns modify the prognostic impact of microvascular invasion in non-cirrhotic hepatocellular carcinoma.
    Meyer YM; Beumer BR; Höppener DJ; Nierop PMH; Doukas M; de Wilde RF; Sprengers D; Vermeulen PB; Verhoef C; IJzermans JNM
    HPB (Oxford); 2022 Apr; 24(4):507-515. PubMed ID: 34393042
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Histopathological tumour microenvironment score independently predicts outcome in primary operable colorectal cancer.
    Hatthakarnkul P; Pennel K; Alexander P; van Wyk H; Roseweir A; Inthagard J; Hay J; Andersen D; Maka N; Park J; Roxburgh C; Thuwajit C; McMillan D; Edwards J
    J Pathol Clin Res; 2024 May; 10(3):e12374. PubMed ID: 38650367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.